Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Sutro Biopharma
Sort By
Newest First
1 / 1
1 / 1
Multiple Myeloma
Sutro's STRO-001 Receives U.S. FDA Orphan Drug Designation for Treatment of Multiple Myeloma
Sutro Biopharma, Inc.
PR-M10-18-NI-049
Oct 15, 2018
